Form 144 - Report of proposed sale of securities:
SEC Accession No. 0002007317-24-000348
Filing Date
2024-03-07
Accepted
2024-03-07 16:36:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4761
  Complete submission text file 0002007317-24-000348.txt   6288
Mailing Address C/O WARNER CHILCOTT CORPORATION 100 ENTERPRISE DRIVE ROCKAWAY NJ 07866
Business Address
Halstead Michael (Reporting) CIK: 0001521548 (see all company filings)

Type: 144

Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Subject) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36274 | Film No.: 24730723
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)